Huagongshe화공사 화학 정보 인쇄 보고서 · 연구 참고용
3-Morpholinecarboxylic acid → 4-((6-(2-Bromo-4-fluorophenyl)-5-(ethoxycarbonyl)-2-(5-methyl-1,3,4-thiadiazol-2-yl)-3,6-dihydropyrimidin-4-yl)methyl)morpholine-3-carboxylic acid
참여 물질
| 역할 | 이름 | HCID | 투입량 |
|---|---|---|---|
| 반응물 | 3-Morpholinecarboxylic acid | HCID 3340152 | — |
| 반응물 | HCID 90043480 | HCID 90043480 | — |
| 생성물 | 4-((6-(2-Bromo-4-fluorophenyl)-5-(ethoxycarbonyl)-2-(5-methyl-1,3,4-thiadiazol-2-yl)-3,6-dihydropyrimidin-4-yl)methyl)morpholine-3-carboxylic acid | HCID 73296292 | 55.4% |
반응 단계
Ethyl 4-(2-bromo-4-fluorophenyl)-6-(bromomethyl)-2-(5-methyl-1,3,4-thiadiazol-2-yl)-1,4-dihydropyrimidine-5-carboxylate (1.04 g, 2 mmol) was reacted with morpholine-3-carboxylic acid (0.26 g, 2 mmol) according to the procedure as described in Example 1, Step C to give the title compound as a yellow solid (0.63 g, 55%). The compound was characterized by the following spectroscopic data:
출처 및 근거
| DOI | 10.6084/m9.figshare.5104873.v1 |
|---|---|
| 특허 번호 | US09340538B2 |
| 출처 데이터셋 | uspto-grants-2016_05 |
| ORD ID | ord-310ac3fada0b4997b134bb48ecfdac30 |
| 출처 메모 | uspto-grants-2016_05 |